Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Recent advances in treating multiple sclerosis: efficacy, risks and place in therapy.
A 60-year follow-up of the incidence and prevalence of multiple sclerosis in Hordaland County, Western Norway.
A Swiss real world best practice experience in three different clinical settings of the 6 hour fingolimod first dose observation procedure.
Oral versus intravenous steroids in multiple sclerosis relapses - a perennial question?
Prorating WAIS-IV Summary Scores for Patients with Relapsing-Remitting Multiple Sclerosis.
Intra-individual variability in information processing speed reflects white matter microstructure in multiple sclerosis.
Revised diagnostic criteria of multiple sclerosis.
Serum and cerebrospinal fluid concentrations of homoarginine, arginine, asymmetric and symmetric dimethylarginine, nitrite and nitrate in patients with multiple sclerosis and neuromyelitis optica.
Linking synaptopathy and gray matter damage in multiple sclerosis.
Perfusion and Diffusion Abnormalities of Multiple Sclerosis Lesions and Relevance of Classified Lesions to Disease Status.
Retinal hemorrhages following fingolimod treatment for multiple sclerosis; a case report.
Immunological follow-up of patients with neuromyelitis optica: Is there a good biomarker?
Promoting remyelination for the treatment of multiple sclerosis: opportunities and challenges.
Coping Among Individuals With Multiple Sclerosis: Evaluating a Goodness-of-Fit Model.
Prognostic factors of acute partial transverse myelitis-reply.
New and Emerging Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis: What is New and What is to Come.
Health-related quality of life among latinos with multiple sclerosis.
The Gap in the Current Research on the Link between Health Locus of Control and Multiple Sclerosis: Lessons and Insights from a Systematic Review.
Regulation: The FDA is overcautious on consumer genomics.
Oxidised LDL lipids, statins and a blood-brain barrier.
Clinicopathological features in anterior visual pathway in neuromyelitis optica.
Two-photon imaging of immune cells in neural tissue.
Drugs that Treat Skin Conditions May Help Combat Multiple Sclerosis.
B-cell depletion in children with neuroimmunologic conditions: The learning curve.
Sevoflurane reduces clinical disease in a mouse model of multiple sclerosis.
Pages
« first
‹ previous
…
403
404
405
406
407
408
409
410
411
…
next ›
last »